Archive | The NeuroCircuit

The NeuroCircuit
Archive
Page -7

Archive

NeurotechnologyNeurotechnology

+6+6

Weekly Signal: 40 | The First Signal of 2026

Foundations, funding, and clarity

Ricardo Albornoz

NeurotechnologyNeurotechnology

+5+5

Weekly Signal: 39 | Clinical Proof, Clearer Signals

Neuromodulation and measurement advance

Ricardo Albornoz

NeurotechnologyNeurotechnology

+6+6

Weekly Signal: 38 | When BCIs Leave the Lab

Regulation, reality, deployment

Ricardo Albornoz

NeurotechnologyNeurotechnology

+7+7

Weekly Signal: 37 | Neurotech Moves Home and Wireless

BCIs, Stimulation, and Scale

Ricardo Albornoz

NeurotechnologyNeurotechnology

+5+5

Weekly Signal: 36 | ALS Trials Accelerate, Ultrasound Advances, MRI Goes Bedside

Critical milestones in modern neurotech

Ricardo Albornoz

NeurotechnologyNeurotechnology

+6+6

Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data

Breakthroughs in Brain Signals and Safety

Ricardo Albornoz

NeurotechnologyNeurotechnology

+4+4

Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy

Signals shaping neurotech’s future

Ricardo Albornoz

Ethics & PolicyEthics & Policy

+5+5

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Decoding, biomarkers, and governance

Ricardo Albornoz

NeurotechnologyNeurotechnology

+6+6

Weekly Signal: 32 | Tiny Implants, Big Governance

Miniaturized BCIs & Global Neuro-Ethics

Ricardo Albornoz

NeurotechnologyNeurotechnology

+6+6

Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights

Clinical data, funding moves, and policy shifts

Ricardo Albornoz

NeurotechnologyNeurotechnology

+4+4

Weekly Signal: 30 | Vision Restored, Minds Regulated: Neurotech’s Pivotal Week

Clinical Breakthroughs & Global Policy Shifts

Ricardo Albornoz

Closed-loop DBSClosed-loop DBS

+6+6

Weekly Signal: 29 | Synapses, Stimulators & Safeguards

Mechanisms, markets, and mental privacy

Ricardo Albornoz